Drugs Information: Venetoclax
Basic Information
|
||
| ID | DDInter1926 | |
| Drug Type | small molecule | |
| Molecular Formula | C45H50Cln7O7S | |
| Molecular Weight | 868.456 | |
| Description | Venetoclax is a BCL-2 inhibitor used to treat chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia. | |
| ATC Classification | L01XX52 | |
| IUPAC Name | 4-(4-{[2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-En-1-Yl]Methyl}Piperazin-1-Yl)-N-(3-Nitro-4-{[(Oxan-4-Yl)Methyl]Amino}Benzenesu | |
| InChI | Inchi=1S/C45H50Cln7O7S/C1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/H3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54) | |
| InChI Key | LQBVNQSMGBZMKD-UHFFFAOYSA-N | |
| Canonical SMILES | CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Venetoclax
| Severity level | ID | Name | Mechanism | Detail |
|---|